ARS Pharmaceuticals (NasdaqGM:SPRY) Q4 2025 Earnings call March 09, 2026 08:30 AM ET Speaker7Good morning and welcome to ARS Pharmaceuticals' fourth quarter and full year 2025 earnings conference call. At this time, all participants are on a listen only mode. After the company's prepared remarks, we will open the line for questions. Please be advised that today's conference is being recorded. I will now turn the call over to Justin Chakma, Chief Business Officer. Please go ahead.Speaker3Good morning. Thank ...